In Vivo Detection of Human TRPV6-Rich Tumors with Anti-Cancer Peptides Derived from Soricidin

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Bowen, Chris V ^a   DeBay, Drew ^a   Ewart, H Stephen ^a,c   Gallant, Pamela ^a   Gormley, Sean ^b   Ilenchuk, T Toney ^b   Iqbal, Umar ^a   Lutes, Tyler ^b   Martina, Marzia ^a   Mealing, Geoffrey ^a   Merkley, Nadine ^a   Sperker, Sandra ^a   Moreno, Maria J ^a   Rice, Christopher ^b   Syvitski, Raymond T ^a   Stewart, John M ^b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b Soricimed Biopharma Inc   (Canada)

^c Novaceutics Consulting   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; FLUORESCENT DYE; SOR C13 PEPTIDE; SOR C27 PEPTIDE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG STRUCTURE; EARLY DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY TUMOR; PROSTATE TUMOR; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TUMOR LOCALIZATION; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; FEMALE; FLUORESCENT DYES; GENE EXPRESSION; HEK293 CELLS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MOLECULAR CONFORMATION; MOLECULAR IMAGING; NEOPLASMS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OPTICAL IMAGING; PEPTIDES; TRANSPLANTATION, HETEROLOGOUS; TRPV CATION CHANNELS;

EID: 84875038780     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058866     Document Type: Article

References (40)

1. Rossing MA, Wicklund KG, Cushing-Haugen KL, Weiss NS, (2010) Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst 102: 222-229.
2. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, et al. (2012) SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). National Cancer Institute. Bethesda, MD.
3. Hoenderop JG, van der Kemp AW, Hartog A, van de Graaf SF, van Os CH, et al. (1999) Molecular identification of the apical Ca2+ channel in 1, 25-dihydroxyvitamin D3-responsive epithelia. J Biol Chem 274: 8375-8378.
4. Peng JB, Chen XZ, Berger UV, Vassilev PM, Tsukaguchi H, et al. (1999) Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. J Biol Chem 274: 22739-22746.
5. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, et al. (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389: 816-824.
6. Montell C, (2003) The venerable inveterate invertebrate TRP channels. Cell Calcium 33: 409-417.
7. Montell C, (2011) The history of TRP channels, a commentary and reflection. Pflugers Arch 461: 499-506.
8. Montell C, Rubin GM, (1989) Molecular characterization of the Drosophila trp locus: a putative integral membrane protein required for phototransduction. Neuron 2: 1313-1323.
9. Gees M, Colsoul B, Nilius B, (2010) The role of transient receptor potential cation channels in Ca2+ signaling. Cold Spring Harb Perspect Biol 2: a003962.
10. Pedersen SF, Owsianik G, Nilius B, (2005) TRP channels: an overview. Cell Calcium 38: 233-252.
11. Wu LJ, Sweet TB, Clapham DE, (2010) International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family. Pharmacol Rev 62: 381-404.
12. Nijenhuis T, Hoenderop JG, Nilius B, Bindels RJ, (2003) (Patho)physiological implications of the novel epithelial Ca2+ channels TRPV5 and TRPV6. Pflugers Arch 446: 401-409.
13. Nijenhuis T, Hoenderop JG, van der Kemp AW, Bindels RJ, (2003) Localization and regulation of the epithelial Ca2+ channel TRPV6 in the kidney. J Am Soc Nephrol 14: 2731-2740.
14. Zhuang L, Peng JB, Tou L, Takanaga H, Adam RM, et al. (2002) Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies. Lab Invest 82: 1755-1764.
15. Bödding M, (2007) TRP proteins and cancer. Cell Signal 19: 617-624.
16. Nilius B, Owsianik G, Voets T, Peters JA, (2007) Transient receptor potential cation channels in disease. Physiol Rev 87: 165-217.
17. Prevarskaya N, Zhang L, Barritt G, (2007) TRP channels in cancer. Biochim Biophys Acta 1772: 937-946.
18. Santoni G, Farfariello V, Amantini C, (2011) TRPV channels in tumor growth and progression. Adv Exp Med Biol 704: 947-967.
19. Bödding M, Wissenbach U, Flockerzi V, (2002) The Recombinant Human TRPV6 Channel Functions as Ca2+Sensor in Human Embryonic Kidney and Rat Basophilic Leukemia Cells. J Biol Chem 277: 36656-36664.
20. Peng JB, Chen XZ, Berger UV, Weremowicz S, Morton CC, et al. (2000) Human calcium transport protein CaT1. Biochem Biophys Res Commun 278: 326-332.
21. Peng JB, Zhuang L, Berger UV, Adam RM, Williams BJ, et al. (2001) CaT1 expression correlates with tumor grade in prostate cancer. Biochem Biophys Res Commun 282: 729-734.
22. Semenova SB, Vassilieva IO, Fomina AF, Runov AL, Negulyaev YA, (2009) Endogenous expression of TRPV5 and TRPV6 calcium channels in human leukemia K562 cells. Am J Physiol Cell Physiol 296: C1098-1104.
23. Wissenbach U, Niemeyer BA, Fixemer T, Schneidewind A, Trost C, et al. (2001) Expression of CaT-like, a novel calcium-selective channel, correlates with the malignancy of prostate cancer. J Biol Chem 276: 19461-19468.
24. Fixemer T, Wissenbach U, Flockerzi V, Bonkhoff H, (2003) Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression. Oncogene 22: 7858-7861.
25. Wissenbach U, Niemeyer B, Himmerkus N, Fixemer T, Bonkhoff H, et al. (2004) TRPV6 and prostate cancer: cancer growth beyond the prostate correlates with increased TRPV6 Ca2+ channel expression. Biochem Biophys Res Commun 322: 1359-1363.
26. Schwarz EC, Wissenbach U, Niemeyer BA, Strauss B, Philipp SE, et al. (2006) TRPV6 potentiates calcium-dependent cell proliferation. Cell Calcium 39: 163-173.
27. Lehen'kyi V, Flourakis M, Skryma R, Prevarskaya N, (2007) TRPV6 channel controls prostate cancer cell proliferation via Ca2+/NFAT-dependent pathways. Oncogene 26: 7380-7385.
28. Bolanz KA, Hediger MA, Landowski CP, (2008) The role of TRPV6 in breast carcinogenesis. Mol Cancer Ther 7: 271-279.
29. Peters AA, Simpson PT, Bassett JJ, Lee JM, Da Silva L, et al. (2012) Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor-negative breast cancer. Mol Cancer Ther 11: 2158-2168.
30. Stewart JM, Steeves BJ, Vernes K, (2006) Paralytic peptide for use in neuromuscular therapy. USPTO. Pat no. 7,119,168.
31. Stewart JM, (2011) Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity. USPTO. Appl No pp. 12/886397.
32. Kim DG, Kang HM, Jang SK, Shin HS, (1992) Construction of a bifunctional mRNA in the mouse by using the internal ribosomal entry site of the encephalomyocarditis virus. Mol Cell Biol 12: 3636-3643.
33. Al-Ansary D, Bogeski I, Disteldorf BM, Becherer U, Niemeyer BA, (2010) ATP modulates Ca2+ uptake by TRPV6 and is counteracted by isoform-specific phosphorylation. FASEB J 24: 425-435.
34. Bödding M, Flockerzi V, (2004) Ca2+ dependence of the Ca2+-selective TRPV6 channel. J Biol Chem 279: 36546-36552.
35. Kovacs G, Montalbetti N, Simonin A, Danko T, Balazs B, et al. (2012) Inhibition of the human epithelial calcium channel TRPV6 by 2-aminoethoxydiphenyl borate (2-APB). Cell Calcium 52: 468-480.
36. Clinchy B, Gazdar A, Rabinovsky R, Yefenof E, Gordon B, et al. (2000) The growth and metastasis of human, HER-2/neu-overexpressing tumor cell lines in male SCID mice. Breast Cancer Res Treat 61: 217-228.
37. Zheng D, Li D, Lu X, Feng Z, (2010) Enhanced antitumor efficiency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicities by intratumoral delivery. Oncol Rep 23: 717-724.
38. Landowski CP, Bolanz KA, Suzuki Y, Hediger MA, (2011) Chemical inhibitors of the calcium entry channel TRPV6. Pharm Res 28: 322-330.
39. Mani V, Briley-Saebo KC, Itskovich VV, Samber DD, Fayad ZA, (2006) Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. Magn Reson Med 55: 126-135.
40. Stuber M, Gilson WD, Schar M, Kedziorek DA, Hofmann LV, et al. (2007) Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON). Magn Reson Med 58: 1072-1077.